HealthPhoto: Hindu HealthImmunotherapy Shows Promise in Treating High-Risk Prostate Cancer
Immunotherapy could become a new treatment option for localized, high-risk prostate cancer when combined with radiotherapy and hormone therapy. While initial results are promising, further research and long-term follow-up are necessary to confirm its benefits and potential inclusion in standard care protocols. The approach aims to enhance existing treatments and improve patient outcomes.
Hindu Health·


